View in EDS HTML Full Text PDF Full Text

Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years.

Saved in:
Bibliographic Details
Title: Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years.
Authors: Sabbagh M; Department of Neurology Barrow Neurological Institute Phoenix Arizona USA., Boschini C; Novo Nordisk A/S Bagsværd Denmark., Cohen S; Toronto Memory Program Toronto Ontario Canada., Fugger M; Novo Nordisk A/S Bagsværd Denmark., Jessen F; Department of Psychiatry University Hospital of Cologne Cologne Germany., Dandanell S; Novo Nordisk A/S Bagsværd Denmark., Pedersen SD; C-endo Diabetes and Endocrinology Clinic Calgary Canada., Tarazona LRS; Novo Nordisk A/S Bagsværd Denmark., Aroda VR; Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA.
Source: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2025 May 06; Vol. 11 (2), pp. e70076. Date of Electronic Publication: 2025 May 06 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40337158
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sabbagh+M%22">Sabbagh M</searchLink>; Department of Neurology Barrow Neurological Institute Phoenix Arizona USA.<br /><searchLink fieldCode="AU" term="%22Boschini+C%22">Boschini C</searchLink>; Novo Nordisk A/S Bagsværd Denmark.<br /><searchLink fieldCode="AU" term="%22Cohen+S%22">Cohen S</searchLink>; Toronto Memory Program Toronto Ontario Canada.<br /><searchLink fieldCode="AU" term="%22Fugger+M%22">Fugger M</searchLink>; Novo Nordisk A/S Bagsværd Denmark.<br /><searchLink fieldCode="AU" term="%22Jessen+F%22">Jessen F</searchLink>; Department of Psychiatry University Hospital of Cologne Cologne Germany.<br /><searchLink fieldCode="AU" term="%22Dandanell+S%22">Dandanell S</searchLink>; Novo Nordisk A/S Bagsværd Denmark.<br /><searchLink fieldCode="AU" term="%22Pedersen+SD%22">Pedersen SD</searchLink>; C-endo Diabetes and Endocrinology Clinic Calgary Canada.<br /><searchLink fieldCode="AU" term="%22Tarazona+LRS%22">Tarazona LRS</searchLink>; Novo Nordisk A/S Bagsværd Denmark.<br /><searchLink fieldCode="AU" term="%22Aroda+VR%22">Aroda VR</searchLink>; Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101650118%22">Alzheimer's & dementia (New York, N. Y.)</searchLink> [Alzheimers Dement (N Y)] 2025 May 06; Vol. 11 (2), pp. e70076. <i>Date of Electronic Publication: </i>2025 May 06 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+on+behalf+of+the+Alzheimer's+Association%22">Wiley on behalf of the Alzheimer's Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101650118 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-8737 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223528737%22">23528737 </searchLink><i>NLM ISO Abbreviation: </i>Alzheimers Dement (N Y) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40337158
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/trc2.70076
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70076
    Titles:
      – TitleFull: Safety considerations of semaglutide in the potential treatment of Alzheimer's disease: A pooled analysis of semaglutide in adults aged ≥ 65 years.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sabbagh M
      – PersonEntity:
          Name:
            NameFull: Boschini C
      – PersonEntity:
          Name:
            NameFull: Cohen S
      – PersonEntity:
          Name:
            NameFull: Fugger M
      – PersonEntity:
          Name:
            NameFull: Jessen F
      – PersonEntity:
          Name:
            NameFull: Dandanell S
      – PersonEntity:
          Name:
            NameFull: Pedersen SD
      – PersonEntity:
          Name:
            NameFull: Tarazona LRS
      – PersonEntity:
          Name:
            NameFull: Aroda VR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 05
              Text: 2025 May 06
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2352-8737
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Alzheimer's & dementia (New York, N. Y.)
              Type: main
ResultId 1